| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer
1 company
Farwell Wildon is a Chief Medical Officer at Dyne Therapeutics, Inc.. Recent SEC Form 4 filings include 0 buys and 5 sells.
Estimated insider holdings value: $3.0M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 13, 2023 | DYN Dyne Therapeutics, Inc. | Chief Medical Officer | Sell | 1,698 | $12.43 | $21,106.14 | -1.8% | -13.1% | +156.5% | |
| Mar 14, 2023 | DYN Dyne Therapeutics, Inc. | Chief Medical Officer | Sell | 7,441 | $13.33 | $99,188.53 | -7.4% | -7.3% | +105.7% | |
| Dec 12, 2022 | DYN Dyne Therapeutics, Inc. | Chief Medical Officer | Sell | 628 | $10.87 | $6,826.36 | -0.6% | +13.1% | -5.9% | |
| Mar 11, 2022 | DYN Dyne Therapeutics, Inc. | Chief Medical Officer | Sell | 640 | $8.73 | $5,587.20 | -1.0% | -38.6% | +49.8% | |
| Mar 2, 2022 | DYN Dyne Therapeutics, Inc. | Chief Medical Officer | Sell | 5,617 | $8.56 | $48,081.52 | -7.8% | -44.6% | +64.8% |